RISW2025
Back to all people

Minghua Shan

Bayer U.S. LLC Pharmaceuticals
1 appearance in the program

Sessions & presentations

PS39:Contributions of Phases: Statistical Considerations in Study Designs and Regulatory Perspectives
Presentation: Panel Discussion: Assessing Contribution of Phases: Challenges and Opportunities
Parallel · Fri, Sep 26 , 10:45 AM
Panelist
↑